Media Coverage: Casey McPherson from AlphaRose Therapeutics to Speak at TechCon Southwest 2026

Markets Insider reported that Casey McPherson, Founder & CEO of AlphaRose Therapeutics, will be a featured speaker at TechCon Southwest 2026, scheduled for February 12–13, 2026 at the Bullock Museum in Austin, Texas. McPherson brings his experience leading innovation in genetic medicine, where his work advancing scalable therapies for rare diseases has positioned him as a notable thought leader in biotech and health technology. His session at TechCon Southwest will take place among panels, keynotes, and discussions that explore emerging technology trends and entrepreneurial strategies across sectors such as AI, digital health, and life sciences. The event, produced by TechCon Global, gathers founders, investors, industry experts, and ecosystem builders to share insights, foster connections, and spotlight innovation leadership.